Barclays on Watson Pharmaceuticals (WPI): Milestone Hit, Feeling Comfort Through 2014

August 24, 2012 1:44 PM EDT Send to a Friend
Barclays maintains an 'Overweight' on Watson Pharmaceuticals (NYSE: WPI) price target of $80.00.

Analyst, Douglas D. Tsao, said, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login